You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 13, 2025

Drug Price Trends for SENNA-S


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for SENNA-S

Average Pharmacy Cost for SENNA-S

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
SENNA-S 8.6-50 MG TABLET 70677-0167-01 0.03085 EACH 2025-04-23
SENNA-S 8.6-50 MG TABLET 70677-0167-01 0.03041 EACH 2025-03-19
SENNA-S 8.6-50 MG TABLET 70677-0167-01 0.02887 EACH 2025-02-19
SENNA-S 8.6-50 MG TABLET 70677-0167-01 0.02860 EACH 2025-01-22
SENNA-S 8.6-50 MG TABLET 70677-0167-01 0.02824 EACH 2024-12-18
SENNA-S 8.6-50 MG TABLET 70677-0167-01 0.02864 EACH 2024-11-20
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Global Sennosides Market Analysis and Price Projections

Introduction

The global sennosides market, driven by the increasing demand for natural laxatives and the rising incidence of digestive disorders, is poised for significant growth over the next decade. Here’s a comprehensive analysis of the market, including its current state, future projections, and key factors influencing its growth.

Current Market Size and Growth Rate

As of 2023, the global sennosides market is valued at approximately US$ 359.5 million. The market is expected to grow at a Compound Annual Growth Rate (CAGR) of 4.3% between 2023 and 2033, reaching a projected market value of US$ 548.5 million by 2033[1][3].

Key Drivers of Market Growth

Several factors are driving the growth of the sennosides market:

Increasing Demand for Natural Laxatives

There is a growing preference for natural and herbal remedies over synthetic laxatives, which is significantly boosting the demand for sennosides. Derived from the Senna plant, sennosides are recognized for their laxative properties and ability to promote regular bowel movements[3].

Rising Incidence of Digestive Disorders

The increasing prevalence of constipation and other digestive disorders worldwide is another key driver. Constipation, in particular, affects a significant portion of the population and can result from various factors, including drug overuse. Sennosides are frequently used as a temporary treatment to relieve constipation and prepare the intestine for procedures like colonoscopies[1].

Health Awareness and Preference for Natural Products

The rising health awareness among consumers and the preference for natural products over synthetic alternatives are further fueling the demand for sennosides. This trend is particularly evident in regions where there is a strong emphasis on natural and herbal remedies for digestive health issues[3].

Market Segmentation

The sennosides market can be segmented based on several criteria:

Drug Type

The sennosides segment leads the global market with a share of around 71.7%, attributed to the easy availability and low cost of sennosides[1].

Dosage Type

Tablets dominate the market with a significant share of 67.57%, indicating their popularity and preference among consumers for convenient and controlled dosage options[3].

Application

Sennosides are primarily used to treat constipation and to empty the large intestine before surgery or procedures like colonoscopies[4].

Distribution Channel

Retail pharmacies capture a market share of 34.63%, highlighting their role as the primary channel for distributing sennoside products to consumers, ensuring accessibility and availability[3].

Regional Analysis

The global sennosides market is diverse, with various regions contributing to its growth:

North America

The United States dominates the sennosides market with a significant market share of 32.5%, reflecting its strong presence and contribution to the global market[3].

Europe

Germany and the UK also hold notable market shares, with Germany capturing 6.3% and the UK showcasing a steady growth rate with a projected CAGR of 4.0% during the forecast period[3].

Asia-Pacific

Countries like China and India present substantial growth opportunities, with China demonstrating a projected CAGR of 4.2% and India showing a higher growth rate with a projected CAGR of 5.9% during the forecast period[3].

Price Analysis

The cost of sennosides can vary based on the dosage form and the pharmacy. For example, Senna-Time S (a combination of docusate and senna) oral tablets can cost around $23 for a supply of 1000 tablets, depending on the pharmacy. Generic versions are also available, which can be more affordable, such as $10.82 for 100 tablets[5].

Market Attractiveness

The market attractiveness of sennosides is high due to several factors:

Growing Demand

The increasing demand for natural laxatives and the rising incidence of digestive disorders make the market highly attractive for manufacturers and distributors.

Low Cost and Easy Availability

The low cost and easy availability of sennosides further enhance their market attractiveness, especially in regions where affordability is a key consideration[1].

Regulatory Environment

While there are no specific regulatory challenges mentioned for sennosides, the overall regulatory environment for pharmaceuticals, including price negotiations and caps, can impact the market. For instance, initiatives like the Medicare Drug Price Negotiation Program aim to reduce drug costs, which could indirectly affect the pricing strategy for sennosides in certain markets[2].

Key Takeaways

  • The global sennosides market is expected to grow at a CAGR of 4.3% between 2023 and 2033.
  • The market is driven by the increasing demand for natural laxatives and the rising incidence of digestive disorders.
  • The United States, Germany, and the UK are significant contributors to the global market.
  • Tablets are the most preferred dosage form, and retail pharmacies are the primary distribution channels.
  • The market is attractive due to the growing demand, low cost, and easy availability of sennosides.

FAQs

  1. What is the current market size of the global sennosides market?

    • The global sennosides market is valued at approximately US$ 359.5 million as of 2023[1].
  2. What is the projected growth rate of the sennosides market between 2023 and 2033?

    • The market is expected to grow at a CAGR of 4.3% between 2023 and 2033[1][3].
  3. Which region dominates the sennosides market?

    • The United States dominates the sennosides market with a significant market share of 32.5%[3].
  4. What are the primary applications of sennosides?

    • Sennosides are primarily used to treat constipation and to empty the large intestine before surgery or procedures like colonoscopies[4].
  5. How much does a supply of Senna-Time S oral tablets typically cost?

    • A supply of 1000 Senna-Time S oral tablets can cost around $23, depending on the pharmacy[5].

Sources

  1. Future Market Insights - Sennosides Market Size, Share, Trend & Outlook by 2033.
  2. CMS - Medicare Drug Price Negotiation Program.
  3. PharmiWeb - Global Sennosides Market, expected to reach US$ 548.5 Million by 2033.
  4. DrugBank Online - Senna leaf.
  5. Drugs.com - Senna-Time S Prices, Coupons, Copay Cards & Patient Assistance.
Last updated: 2024-12-31

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.